Vlad Batagui
About Vlad Batagui
Vlad Batagui is a Research Associate at Entrada Therapeutics, where he has worked since 2021. He studied Chemistry and Statistics at Harvard University, earning A.B. Honors, and has held various research positions at prestigious institutions.
Work at Entrada Therapeutics
Vlad Batagui has been employed at Entrada Therapeutics as a Research Associate since 2021. In this role, he contributes to the company's research initiatives, focusing on the development of innovative therapeutic solutions. His position involves collaboration with a team of scientists and researchers to advance the understanding of drug delivery systems and their applications in treating various diseases.
Education and Expertise
Vlad Batagui studied at Harvard University from 2017 to 2021, where he pursued a degree in Chemistry and Statistics. He achieved A.B. Honors Candidate status during his studies. Prior to Harvard, he completed his high school education at Colegiul National de Informatica Tudor Vianu, earning a High School Diploma with a focus on Mathematics and Computer Science from 2013 to 2017.
Research Experience at Harvard University
During his time at Harvard University, Vlad Batagui worked as an Undergraduate Student Researcher in the Shakhnovich Lab from 2019 to 2021. This two-year experience allowed him to engage in significant research projects, contributing to the lab's focus on protein folding and computational biology. His involvement in research at Harvard provided him with valuable skills and insights into scientific inquiry.
Previous Work Experience
Vlad Batagui has diverse work experience in research and education. He served as a Tour Guide at Harvard Art Museums from 2018 to 2021, where he engaged with visitors and shared knowledge about the museum's collections. Additionally, he participated in the Amgen Scholars program at Kyoto University for two months in 2019, gaining international research exposure. He also worked as an Undergraduate Student Researcher at Technische Universiteit Delft in the Laan Lab for three months in 2018.